Phage Safety Cohort Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospices Civils de Lyon
About this trial
This cohort study aims to describe the adverse events related to the use of bacteriophages to treat serious infections, data from the literature being almost non-existent on this subject.
Eligibility criteria
Qualifiers
Patient 18 years of age or older with a serious infection treated at CRIOAc Lyon by phage therapy
Patient who did not object to participating in the study
Patients ayant un poids minimum de 46kg
Disqualifiers
Patients under guardianship/curatorship
Patients deprived of liberty
Pregnant or breastfeeding women
Trial design
Treatments tested in this trial
- Adverse event after injection of phages
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
1Hospices Civils de Lyon69004, Lyon France
Sponsors and collaborators
Hospices Civils de Lyon
Lead sponsor
Source ClinicalTrials.gov